This bill reschedules marijuana from the most restrictive Schedule I to Schedule III under federal law. It requires the Attorney General to issue an order effecting this change within 60 days of the bill's enactment. This classification shift would make marijuana less restricted federally, affecting all federal regulations and penalties related to the substance. The change directly impacts federal enforcement, research, and medical access policies for marijuana nationwide.
HR 394, the "Holding Child Predators Accountable Act," amends federal laws to impose mandatory death or life imprisonment for certain child pornography offenses. It changes penalties under Title 18 for possession (Section 1466A), exploitation (Section 2252), and distribution (Section 2252A) of child sexual abuse material, replacing prior penalty structures with the maximum sentence. This directly affects individuals convicted of violating these specific provisions, including those involving possession, distribution, or production of such material. The bill makes no new offenses but mandates the harshest possible penalties for existing violations under these sections.
This bill removes barriers for people with past drug-related convictions to access federal assistance programs. It amends welfare law to allow states to provide Temporary Assistance for Needy Families (TANF) benefits to individuals with such convictions and prohibits states from denying Supplemental Nutrition Assistance Program (SNAP) benefits based on drug convictions. The bill also adds "incarcerated individuals scheduled for release within 30 days" to SNAP household eligibility criteria. These changes directly affect individuals with past drug convictions seeking welfare or food assistance, removing state-level restrictions that previously barred them.
The GOSAFE Act prohibits the sale, manufacture, transfer, and possession of gas-operated semi-automatic firearms and large capacity ammunition feeding devices (those holding more than 10 rounds). It defines gas-operated firearms as those that use gas from fired cartridges to cycle the action, requiring the Attorney General to publish a list of prohibited firearms within 180 days. The bill establishes a process for manufacturers to seek approval for new firearm designs before selling to civilians and creates a "Firearm Safety Trust Fund" to cover related costs. Certain firearms are exempt, including single-shot, muzzle-loading, and firearms with permanently fixed magazines holding 10 or fewer rounds. Violations could result in fines up to $5,000 or up to 12 months in prison.
This bill prohibits federal funding for any state, local, tribal, or private entity operating an injection center that violates the Controlled Substances Act's Crack House Statute (21 U.S.C. 856), which bans drug use in buildings. It directly affects organizations running facilities where illegal drug use occurs, cutting off all federal grants or programs from such entities. The law does not create new drug offenses but withholds existing federal funds from facilities operating in violation of current law. It applies broadly to all federal funding streams, not just specific programs.
HR 4991, the Disarming Felons Act, prohibits the sale or transfer of firearms to, and possession of firearms by, adults who committed an act as a juvenile (aged 15-17) that would have been a felony if committed as an adult. The bill amends existing federal law (18 U.S.C. §§ 922(d) and 922(g)) to add this new category to the list of prohibited firearm transactions and possession. It directly affects individuals who were juveniles at the time of a serious offense but are now adults, restricting their access to firearms. The law creates a specific legal barrier to firearm access based on the severity of a juvenile offense, without altering penalties for the offense itself.
The Fatal Overdose Reduction Act of 2025 establishes a Medicaid demonstration program to create "Health Engagement Hubs" that provide comprehensive, drop-in services for people with opioid use disorder and other substance use disorders. These hubs would offer harm reduction services, medication-assisted treatment, counseling, and social services like housing assistance and job training, with a focus on communities disproportionately impacted by overdose deaths. States would develop payment systems for these services, with up to 10 states selected to participate for 5 years, and would be required to report on outcomes like overdose rates and treatment access. The program would be funded through a $60 million planning grant and would require states to track demographic and health outcomes to assess effectiveness.
HR 5032, the Nitazene Control Act, permanently classifies all nitazenes and their chemical analogs as Schedule I controlled substances under the Controlled Substances Act. This means these synthetic opioids, which are significantly more potent than fentanyl and linked to overdose deaths, are now federally banned for all non-medical use. The bill creates a broad chemical definition covering substances with specific structural features (a benzimidazole core and mu-opioid receptor activity), preventing new analogs from evading regulation. It includes a temporary 18-month exemption for researchers already studying these substances under active FDA-approved protocols, requiring them to notify the DEA and apply for proper registration within that period. The law directly affects the illicit drug market and ongoing research involving nitazenes, aiming to streamline enforcement and prevent new analogs from entering the supply chain.
HR 7184, the PRESS Act, targets equipment used to manufacture illegal drugs by making it unlawful to sell specific items like tableting machines, gelatin capsules, or related chemicals when the seller knows the equipment will be used to produce controlled substances for unlawful U.S. importation. It directly affects manufacturers and distributors of these drug-making tools who have knowledge or reasonable cause to believe their products will facilitate illegal drug trafficking. The bill adds new prohibitions to the Controlled Substances Act and increases potential prison sentences for violations, with penalties reaching up to 20 years for major offenses involving large quantities of equipment or chemicals. These changes aim to disrupt the supply chain for illicit synthetic drugs by holding equipment sellers accountable for their intended use.
HR 4405, the Epstein Files Transparency Act, requires the U.S. Attorney General to publicly release all unclassified Department of Justice documents related to Jeffrey Epstein within 30 days of the law’s enactment. This includes investigations, flight logs, immunity deals, internal communications, and records about Epstein’s detention or death, while prohibiting redactions for "embarrassment" or political sensitivity. The law allows limited redactions only for victim privacy, child sexual abuse materials, active investigations, or national security (with justification), and mandates an unclassified summary for withheld classified information. The Attorney General must submit a detailed report to Congress within 15 days of release, listing all redactions and naming any government officials referenced in the materials.
